FDA expands approval of first gene therapy for rare form of muscular dystrophy
By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation. Last year, the drug – Elevidys, from the biotech company
Continue Reading